Evaluation by metabolic profiling and in vitro autoradiography of two promising GnRH-receptor ligands for brain SPECT imaging.

Autor: Fjellaksel R; Nuclear Medicine and Radiation Biology Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Drug Transport and Delivery Research Group, Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway.; Organic Chemistry Research Group, Department of Chemistry, UiT The Arctic University of Norway, Tromsø, Norway.; The PET Imaging Center, University Hospital of North Norway, Tromsø, Norway., Moldes-Anaya A; Nuclear Medicine and Radiation Biology Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; The PET Imaging Center, University Hospital of North Norway, Tromsø, Norway.; Pharmacology Research Group, Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway.; Neurobiology Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Vasskog T; Natural Products and Medicinal Chemistry Research group, UiT The Arctic University of Norway, Tromsø, Norway., Oteiza A; Nuclear Medicine and Radiation Biology Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; The PET Imaging Center, University Hospital of North Norway, Tromsø, Norway., Martin-Armas M; Nuclear Medicine and Radiation Biology Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; The PET Imaging Center, University Hospital of North Norway, Tromsø, Norway., Hjelstuen OK; Nuclear Medicine and Radiation Biology Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; Drug Transport and Delivery Research Group, Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway., Hansen JH; Organic Chemistry Research Group, Department of Chemistry, UiT The Arctic University of Norway, Tromsø, Norway., Riss PJ; Department of Neuropsychiatry and Psychosomatic Medicine, Oslo University Hospital, Oslo, Norway.; Realomics SFI, Department of Chemistry, University of Oslo, Oslo, Norway.; Norsk Medisinsk Syklotronsenter AS, Oslo, Norway., Sundset R; Nuclear Medicine and Radiation Biology Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.; The PET Imaging Center, University Hospital of North Norway, Tromsø, Norway.
Jazyk: angličtina
Zdroj: Journal of labelled compounds & radiopharmaceuticals [J Labelled Comp Radiopharm] 2020 Feb; Vol. 63 (2), pp. 72-84. Date of Electronic Publication: 2020 Jan 15.
DOI: 10.1002/jlcr.3820
Abstrakt: The increased expression of gonadotropin releasing hormone receptor (GnRH-R) in brain has been strongly linked to Alzheimer disease. Therefore, the development of radiolabeled imaging agents for GnRH-R is relevant for early diagnosis of Alzheimer disease. We have recently disclosed the discovery of two promising compounds displaying nanomolar-range affinity for the GnRH-R. In the present study, a preclinical evaluation of the compound properties was performed to evaluate their potential as single photon emission computed tomography (SPECT) radiotracers for imaging the GnRH-receptor. The compounds were assessed in vitro by performing serum stability analysis by human and rat serum, metabolic profiling by human liver microsomes, and exploratory rat brain autoradiography. The investigated compounds displayed satisfactory stability against human, rat serum, and liver microsomal metabolism, which favors their potential as SPECT-imaging agents. Additionally, we identified and quantified the formation rate of the metabolites by fragmentation of up to five mass spectrometric stages. The GnRH-R rat brain specificity of these compounds was tested in competition with a known ligand for the receptor and the in vitro autoradiography confirmed that compounds 3 and 4 binds to rat GnRH-R in different rat brain regions.
(© 2019 The Authors. Journal of Labelled Compounds and Radiopharmaceuticals published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje